Gong Qing, MD

Gong Qing, MD, is Associate Medical Director for Fortrea Clinical Development Services, based in Shanghai, China.

George Vamvakias

• 33 years in industry with experience in pharmaceutical and medical device product development 
• 28 years in Project Management roles 
• Career spans both CRO and Pharma/Biologics/Med Device roles 
• Project M

Friedrich Wieser, MD

Friedrich (Fritz) Wieser, MD, is an OB/GYN who received his MD from the Vienna Medical University (Vienna, Austria). After completing his gynecology residency at the Dept.

Frederick Derosier, DO

Frederick Derosier, DO, is the Head of Fortrea’s Rare Diseases, Advanced Therapies and Pediatrics Team (RAPT). He has 22 years of experience in the pharma/biotech industry and 10 years of clinical practice in Internal Medicine.

Franklin Gaylis, MD, FACS

Franklin Gaylis, MD, FACS, is a Urology Consultant at Fortrea.

Dobrica Neric, MD

Dobrica Neric, MD, is a Medical Director for Oncology, based in Belgrade, Serbia. Dr. Neric is a specialist of Internal Medicine and sub-specialist of Medical Oncology and has more than 20 years of clinical experience as a physician.

Diana Aguirre, MD

Diana Aguirre, MD, is Senior Medical Director in oncology for Fortrea Clinical Development Services, based in France. Dr.

David Hoelscher, MD

Dr. Hoelscher is based in Austin, Texas with 24 years of CRO industry experience in a wide variety of therapeutic areas, most recently in the past 16 years focusing on medical monitoring in ophthalmology indications including: 

Darby Thomas, PhD

Darby Thomas, PhD, is the Scientific Director of Fortrea’s Rare Diseases, Advanced Therapies and Pediatrics Team (RAPT).

Daniel Gandia, MD

Dr. Gandia is a physician with more than 30 years of experience in clinical oncology and the pharmaceutical industry.